![Luc Debruyne](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Mr. Luc Debruyne is a Chairman at Fund+ NV and a Member-Life Sciences Board at GreenLight Biosciences, Inc. He is on the Board of Directors at Global Listening Project VZW and Universitair Ziekenhuis Leuven.
Mr. Debruyne was previously employed as a Chairman by Bavarian Nordic A/S, an Independent Director by Renovaro, Inc., and a President-Vaccines by GSK Plc.
He received his graduate degree from Katholieke Universiteit Leuven.
Postes actifs de Luc Debruyne
| Sociétés | Poste | Début |
|---|---|---|
GreenLight Biosciences, Inc.
 GreenLight Biosciences, Inc. BiotechnologyHealth Technology Develops biotechnology and life sciences | Corporate Officer/Principal | - |
Universitair Ziekenhuis Leuven | Directeur/Membre du Conseil | - |
Fund+
 Fund+ Investment ManagersFinance Fund+ invests in companies located in Europe primarily in Belgium. The firm focuses on the life sciences primarily active in therapeutics, as well as companies developing diagnostics and medical devices.. It participates in early stage capital requirements with an investment of EUR 5 - 15 million. The firm acquires minority interest and takes a seat on the board of directors. It also makes co-investments and subsequent financing. | Président | 01/10/2019 |
Z.org KU Leuven
 Z.org KU Leuven Hospital/Nursing ManagementHealth Services Provides psychiatric care services | Directeur/Membre du Conseil | - |
Anciens postes connus de Luc Debruyne
| Sociétés | Poste | Fin |
|---|---|---|
| BAVARIAN NORDIC A/S | Président | 13/11/2025 |
| LUNAI BIOWORKS INC. | Directeur/Membre du Conseil | 31/12/2019 |
| GSK PLC | Corporate Officer/Principal | - |
Formation de Luc Debruyne
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
57
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Lunai Bioworks, Inc.
 Lunai Bioworks, Inc. BiotechnologyHealth Technology Operates as preclinical stage biotechnology company developing technologies and therapies for HIV, HBV and cancer | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Bavarian Nordic A/S
 Bavarian Nordic A/S BiotechnologyHealth Technology Engages in research, development and manufacturing travel vaccines | Health Technology |
Katholieke Universiteit Leuven
 Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GreenLight Biosciences, Inc.
GreenLight Biosciences, Inc. BiotechnologyHealth Technology Develops biotechnology and life sciences | Health Technology |
Universitair Ziekenhuis Leuven | |
Fund+
Fund+ Investment ManagersFinance Fund+ invests in companies located in Europe primarily in Belgium. The firm focuses on the life sciences primarily active in therapeutics, as well as companies developing diagnostics and medical devices.. It participates in early stage capital requirements with an investment of EUR 5 - 15 million. The firm acquires minority interest and takes a seat on the board of directors. It also makes co-investments and subsequent financing. | Finance |
Z.org KU Leuven
Z.org KU Leuven Hospital/Nursing ManagementHealth Services Provides psychiatric care services | Health Services |
